|
End-of-day quote
Buenos Aires S.E.
2026-11-05
|
5-day change | 1st Jan Change | ||
| 31,260.00 ARS | -4.81% |
|
-1.39% | +50.72% |
| 10-29 | Biogen Presents New Data Across Alzheimer?S Disease Portfolio At CTAD 2026 | CI |
| 10-29 | Biogen Swings Back to Growth as Stock Momentum Could Continue, RBC Says | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| BIOGEN INC. | Biopharmaceuticals | -4.81% | -1.39% | +50.72% | +78.94% | +578.39% | 36.06B |
-
|
-
|
-
|
- Stock Market
- Stocks
- BIIB Stock
- BIIB Stock
- Charts Biogen Inc.
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
